News

ArisGlobal: Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere NavaX
Global Biopharma Leader Streamlines Pharmacovigilance with 90% Data Accuracy and Enhanced Efficiency BOSTON, July 8, 2025 /PRNewswire/ -- ArisGlobal, an AI-first technology company at the ...
Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere® NavaX™
ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced that ...
Global vaccine group Gavi has $9 billion, short of its target
Global vaccine group Gavi has more than $9 billion for its work over the next five years helping to immunize the world's ...
Law19d
Cybersecurity and AI: What Clients Really Think - Law.com
Discover where your firm stands in comparison to industry benchmarks—and what actionable strategies can help yougain a competitive edge.
AdnKronos1mon
Sixth Global Pharma Company Selects LifeSphere NavaX for ... - Adnkronos
Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies ...
KTLA1mon
Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI ... - KTLA
This announcement further cements LifeSphere NavaX as the innovation driver of choice for global pharma organizations seeking to accelerate, more intelligent workflows across the span of R&D IT ...
WCBD1mon
Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven ...
Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies BOSTON, June 3, 2025 /PRNewswire/ -- ArisGlobal, an innovative ...